LONDON, June 21 (Reuters) - Shire Plc said on Thursday the U.S. Food and Drug Administration (FDA) intended to approve Intuniv, its extended-release, non-stimulant treatment for attention deficit ...
LONDON, July 28 (Reuters) - U.S. regulators have delayed approval of Shire's new extended-release hyperactivity drug Intuniv but the British company still expects it to be launched in the United ...
Verywell Health on MSN
What is ADHD (attention deficit hyperactivity disorder)?
Medically reviewed by Steven Gans, MD Key Takeaways ADHD symptoms often start in childhood and can affect success at school, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback